They have received reports of possible serious side effects in the form of fatal blood clots
The Danish Directorate General of Health announced the temporary suspension of AstraZeneca vaccine after registering a “severe thrombosis case” among people receiving AstraZeneca vaccine.
The Danish Minister of Health Magnus Heunicke stated that this is a preventive measure. Previously, “there may be serious side effects in the form of fatal blood clots.”
He said in a tweet that Denmark chose to take action as soon as possible and will conduct a thorough investigation into the incident.
AstraZeneca said in a statement: “The safety of the vaccine has been extensively studied in phase III clinical trials, and peer-reviewed data confirms that the vaccine is generally well tolerated.”
After the news came out, the drug maker’s stock price fell 2.7%.
The Danish incident occurred before the Austrian news release. In Austria, there were reports that one person died of the vaccine and the other was sick. The authorities suspended a batch of AstraZeneca vaccines last weekend.
The European Medicines Agency (EMA) said on Wednesday that its safety committee is investigating the reported cases in Austria, but there is currently no indication that the vaccine has caused a blood clot.
Denmark’s decision was made after reports of a death in the country, although the authorities emphasized that it is currently impossible to conclude that there is a link between these events and the AstraZeneca vaccine.
Even so, the country will still suspend the use of the vaccine for two weeks, and a new assessment will be conducted on March 22.
Danish Prime Minister Met Fredriksen said that Denmark needs “further investigation.”
He said: “We are sorry to receive this news, and it is too early to say what this means for our immunization program.”
With information from EFE and Bloomberg